BIOTRONIK Blog Explore our latest insightful interviews and articles Image Blog Stories Filter and Search Filter by year - Any -20242023202220212020 Filter by category - Any -3D Mapping60 YearsAblationAcutus MedicalAFibAlCath ForceAmviaAngioplastyAsia Pacific Manufacturing and Research Hubat HomeAtrial FibrillationAUSAutoAdaptAwarenessBalloon CatheterBetter ClimateBIO REACTBIO-LIBRABioEnvelopeBIOFLEX-IBIOFLOWBIOFLOW-VBIOHELIXBIOLIBRABIOLUXBIOMAGBIOMAG-IBIOMONITORBIOMONITOR IIIBIOMONITOR IIImBIOMONITORIIImBIONETIC-IBIOPACTBIOSOLVEBIOSOLVE-IVBIOSTEMIBIOTRONIK CanadaBIOTRONIK JapanBIOTRONIK Patient AppBIOTRONIK USBIOWOMENBlogblogBMIIIBradycardiaBurnoutCanadaCardiac ArrestCardiac DevicesCardiac Implantcardiac monitorcardiacmonitorsCardiologyCardiology InsightsCardiology insightsCardioSphereCardiovascular DiseaseCardiovascular HealthCareerCareersCASTLE-AFCatheterCE ApprovalCE MarkCertificationCharing CrossChineseChronic PainCIRSEClinical DataClinical Staffclinical studiesClinical Studiesclinical studyClinical StudyClinical studyClinical TrialsClinical Trials DayClinicsClosed Loop StimulationCLSCode of Business ConductCompany CultureCompany MilestoneCompany ValuesComplianceconduction system pacingConduction System PacingCongresscongressCoronaryCoronary Artery DiseaseCorporate Social ResponsibilityCOVID-19CPRCRMCRTCRT-DCRT-PCryptogenic StrokeCSPCSRCybersecuritycybersecurityCzechData ProtectionDCBDESdiagnosticsDietDigital HealthDonationDREAMS 3GDrug-Coated BalloonDXDX TechnologyDynetic-35ECGECGsEdoraEHRAelectromagnetic fieldsEmployee EngagementEmployee WellbeingEndovascular ProceduresEnvironmentEPEqual RepresentationEqualityESCESC CongressespanaespanolEthicsEuroPCREuropean UnionEventeventEvityExcerciseFDAFDA ApprovalFirst ImplantFoodFortressFrenchGDPRGoldTipHBPHealth & WellnessHealth DataHealth InitiativeHealth TipsHeartHeart AttacksHeart FailureHeart HealthHeartInsightHemodialysisHis BundleHis-bundleHis-bundle pacingHistoryHome Monitoringhome monitoringHuman RightsICDICMImplantImplantable Cardiac MonitorIN-TIMEInsertable Cardiac MonitorsInside BIOTRONIKInsight BIOTRONIKInternational Women's DayInterventional CardiologyInterviewInticaIntroducer SheathsJapanLaunchLBBAPLINCMagmarisMaking a DifferenceMaking A DifferenceManufacturingMarathonMATRIX studyMATRIX StudyMDRMental HealthMoMeMonitoringMRIMultiPole PacingMyocardial InfarctionSustainabilityNeuro NewsNeurologyNew Year's ResolutionsNursesOccupational SafetyOrsiroOrsiro MissionOscarPacemakerpacemakerPacemakerspacemakersPAD TreatmentPasseoPasseo-18 LuxPasseo-35 XeoPatientPatient AppPatient CarePatient DayPatient QuestionsPatient SafetyPatientsPCIPeripheralPhysician Well-BeingPK PapyrusPlexaPollutionportuguesportuguesePortuguesePRPress releasepress releasePRO-KineticProMRIPulsarPulsar-18Pulsar-18 T3QP ExCELsR&DRadiationREACT DXReading RecommendationRehabilitationReimbursementRelativesRemote cardiac monitoringRemote Careremote monitoringRemote MonitoringResearchResorbable Magnesium ScaffoldResorbale ScaffoldsRhythmCheckRivacorRMSSafetyScaffoldScansScienceSCSSelectra 3DSELENE HFSENSESentusSingaporeSmall Coronary VesselsSmartphoneSoftwareSpainSpanishspanishSportsStatementSTEMIStentStoryStrokeStudiesStudystudySupply ChainSyncopeTachycardiaTCTTelemedicineTHINGSTIMELYTraining & EducationTravelTRCTrendsTrialTRUECOINUKVacationVIwebinarWebinarWomenWomen in CardiologyWorkflowZero-GravityCardiac Rhythm ManagementCorporateElectrophysiologyNeuromodulationPress ReleaseVascular Intervention Search 12 blog articles Image March 7, 2024 Blog Improving Cardiovascular Health This International Women’s Day Image February 14, 2024 Blog How Love Benefits Your Heart Health Exploring the Science Behind Love's Cardiovascular Benefits Image January 31, 2024 Blog BIOTRONIK Employees Donate Over 14,000 Euros to the Arche Berlin-Hellersdorf A Donation Ceremony Took Place at the Woermannkehre, on January 18, 2024 Image December 22, 2023 Blog Gold Standard for Two Decades: Why the Use of GoldTip is Still Unbeaten in Certain Ablation Procedures In the midst of celebrating 60 years of service in partnership with the healthcare community, BIOTRONIK’s Electrophysiology business marked another important milestone of its own in 2023 – its 20 th anniversary. Image December 12, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Continues 2023 was a landmark year for BIOTRONIK – not simply in name or number – but in action. The company’s 60 th year of operations was a busy one for lifesaving innovations like the Amvia pacemaker and CRT-P family and Oscar catheter, to laying the groundwork for helping a whole new community of patients with the Prospera TM spinal cord stimulation system, a BIOTRONIK first. Image December 11, 2023 Blog Vascular Revolution Spurs Overdue Update to Radiation Guidelines Prof. Anders Wanhainen Highlights New ESVS Recommendations, Advising on Suspended Personal Radiation Protection Systems for the First Time Image October 20, 2023 Blog Unveiling Hidden Atrial Fibrillation: Implications for Stroke Prevention in ICD Patients New Research Confirms Effective Tools to Better Protect Patients with High Stroke Risk Image April 6, 2023 Blog How Much Exercise Is Enough for a Healthy Heart? Recent Studies Reveal Optimal Levels of Physical Activity for Cardiovascular Health Image July 28, 2022 Blog Sport For Pacemaker or Defibrillator Patients – How to Get Started Again? Pagination Current page 1 Page 2 Next page Next › Subscribe for our News You must have JavaScript enabled to use this form. Title Select TitleMsMrMXDrProf First name Last name Role Please select your roleHealthcare ProfessionalPatient or RelativeJournalistOther Email Phone Country/Region - Select -AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua & BarbudaArgentinaArmeniaArubaAscension IslandAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia & HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCanary IslandsCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicCeuta & MelillaChadChileChinaChristmas IslandClipperton IslandCocos (Keeling) IslandsColombiaComorosCongo - BrazzavilleCongo - KinshasaCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d’IvoireDenmarkDiego GarciaDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard & McDonald IslandsHondurasHong Kong SAR ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao SAR ChinaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorth KoreaNorth MacedoniaNorwayOmanOutlying OceaniaPakistanPalauPalestinian TerritoriesPanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSamoaSan MarinoSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia & South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSt. BarthélemySt. HelenaSt. Kitts & NevisSt. LuciaSt. MartinSt. Pierre & MiquelonSt. Vincent & GrenadinesSudanSurinameSvalbard & Jan MayenSwedenSwitzerlandSyriaSão Tomé & PríncipeTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad & TobagoTristan da CunhaTunisiaTurkeyTurkmenistanTurks & Caicos IslandsTuvaluU.S. Outlying IslandsU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis & FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Topic Please select a topicProductsPatientsHealthcare Professionals I prefer to be contacted by Phone Email Message *Fields are mandatory. Latest Press Releases Show all press releases Image May 17, 2024 BUELACH, SWITZERLAND Press Release BIOMAG-I Two-Year Study Results Confirm Excellent Safety and Efficacy Profile for Freesolve, BIOTRONIK’s Newest Resorbable Magnesium Scaffold Innovation New two-year follow-up data from the BIOMAG-I first-in-human trial confirms a reliable and predictable long-term safety profile for Freesolve™, the third-generation resorbable magnesium scaffold (RMS), establishing it as a true alternative to contemporary drug-eluting stents (DES). The results were presented by Prof. Dr. Michael Haude at the EuroPCR 2024 conference yesterday in Paris. At the 24-month follow-up, the incidence of target lesion failure (TLF) was 3.5% alongside a corresponding 3.5% incidence of target lesion revascularization (TLR) compares favorably with various second-generation Image May 13, 2024 BUELACH, SWITZERLAND Press Release New-Gen Resorbable Magnesium Scaffold Freesolve Enters BIOMAG-II Randomized Controlled Trial (RCT) BIOTRONIK announced today the enrollment of the first patient in the BIOMAG-II trial aiming to evaluate the safety and clinical performance of its new-generation resorbable magnesium scaffold (RMS), Freesolve™, compared to a contemporary drug-eluting stent (DES). "We are delighted to enroll the first patient in the BIOMAG-II trial, which may play a critical role in helping establish resorbable metallic scaffolds as part of clinical practice in the future and I am particularly encouraged by the implantation results of the Freesolve resorbable magnesium scaffold," said Dr. Juan F. Iglesias, HUG Image April 22, 2024 BERLIN, Germany Press Release BIOTRONIK and Texray Establish Collaboration to Distribute Texray’s Innovative Radiation Protection Products BIOTRONIK , a leading global medical technology company specializing in innovative cardiovascular and endovascular solutions, proudly announces a multinational distribution partnership with Texray, the pioneering developer of a groundbreaking radiation protection textile. In this collaboration BIOTRONIK will distribute Texray's head and neck protectors starting in selected European and Middle Eastern countries. Both partners aim to raise awareness about the critical importance of radiation protection for healthcare professionals, who serve in environments where radiation exposure is an Press Contact Corporate Public Relations & Communications press@biotronik.com +49 (0) 30 68905 1414 Get in contact
Image February 14, 2024 Blog How Love Benefits Your Heart Health Exploring the Science Behind Love's Cardiovascular Benefits
Image February 14, 2024 Blog How Love Benefits Your Heart Health Exploring the Science Behind Love's Cardiovascular Benefits
Image January 31, 2024 Blog BIOTRONIK Employees Donate Over 14,000 Euros to the Arche Berlin-Hellersdorf A Donation Ceremony Took Place at the Woermannkehre, on January 18, 2024
Image January 31, 2024 Blog BIOTRONIK Employees Donate Over 14,000 Euros to the Arche Berlin-Hellersdorf A Donation Ceremony Took Place at the Woermannkehre, on January 18, 2024
Image December 22, 2023 Blog Gold Standard for Two Decades: Why the Use of GoldTip is Still Unbeaten in Certain Ablation Procedures In the midst of celebrating 60 years of service in partnership with the healthcare community, BIOTRONIK’s Electrophysiology business marked another important milestone of its own in 2023 – its 20 th anniversary.
Image December 22, 2023 Blog Gold Standard for Two Decades: Why the Use of GoldTip is Still Unbeaten in Certain Ablation Procedures In the midst of celebrating 60 years of service in partnership with the healthcare community, BIOTRONIK’s Electrophysiology business marked another important milestone of its own in 2023 – its 20 th anniversary.
Image December 12, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Continues 2023 was a landmark year for BIOTRONIK – not simply in name or number – but in action. The company’s 60 th year of operations was a busy one for lifesaving innovations like the Amvia pacemaker and CRT-P family and Oscar catheter, to laying the groundwork for helping a whole new community of patients with the Prospera TM spinal cord stimulation system, a BIOTRONIK first.
Image December 12, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Continues 2023 was a landmark year for BIOTRONIK – not simply in name or number – but in action. The company’s 60 th year of operations was a busy one for lifesaving innovations like the Amvia pacemaker and CRT-P family and Oscar catheter, to laying the groundwork for helping a whole new community of patients with the Prospera TM spinal cord stimulation system, a BIOTRONIK first.
Image December 11, 2023 Blog Vascular Revolution Spurs Overdue Update to Radiation Guidelines Prof. Anders Wanhainen Highlights New ESVS Recommendations, Advising on Suspended Personal Radiation Protection Systems for the First Time
Image December 11, 2023 Blog Vascular Revolution Spurs Overdue Update to Radiation Guidelines Prof. Anders Wanhainen Highlights New ESVS Recommendations, Advising on Suspended Personal Radiation Protection Systems for the First Time
Image October 20, 2023 Blog Unveiling Hidden Atrial Fibrillation: Implications for Stroke Prevention in ICD Patients New Research Confirms Effective Tools to Better Protect Patients with High Stroke Risk
Image October 20, 2023 Blog Unveiling Hidden Atrial Fibrillation: Implications for Stroke Prevention in ICD Patients New Research Confirms Effective Tools to Better Protect Patients with High Stroke Risk
Image April 6, 2023 Blog How Much Exercise Is Enough for a Healthy Heart? Recent Studies Reveal Optimal Levels of Physical Activity for Cardiovascular Health
Image April 6, 2023 Blog How Much Exercise Is Enough for a Healthy Heart? Recent Studies Reveal Optimal Levels of Physical Activity for Cardiovascular Health
Image May 17, 2024 BUELACH, SWITZERLAND Press Release BIOMAG-I Two-Year Study Results Confirm Excellent Safety and Efficacy Profile for Freesolve, BIOTRONIK’s Newest Resorbable Magnesium Scaffold Innovation New two-year follow-up data from the BIOMAG-I first-in-human trial confirms a reliable and predictable long-term safety profile for Freesolve™, the third-generation resorbable magnesium scaffold (RMS), establishing it as a true alternative to contemporary drug-eluting stents (DES). The results were presented by Prof. Dr. Michael Haude at the EuroPCR 2024 conference yesterday in Paris. At the 24-month follow-up, the incidence of target lesion failure (TLF) was 3.5% alongside a corresponding 3.5% incidence of target lesion revascularization (TLR) compares favorably with various second-generation
Image May 17, 2024 BUELACH, SWITZERLAND Press Release BIOMAG-I Two-Year Study Results Confirm Excellent Safety and Efficacy Profile for Freesolve, BIOTRONIK’s Newest Resorbable Magnesium Scaffold Innovation New two-year follow-up data from the BIOMAG-I first-in-human trial confirms a reliable and predictable long-term safety profile for Freesolve™, the third-generation resorbable magnesium scaffold (RMS), establishing it as a true alternative to contemporary drug-eluting stents (DES). The results were presented by Prof. Dr. Michael Haude at the EuroPCR 2024 conference yesterday in Paris. At the 24-month follow-up, the incidence of target lesion failure (TLF) was 3.5% alongside a corresponding 3.5% incidence of target lesion revascularization (TLR) compares favorably with various second-generation
Image May 13, 2024 BUELACH, SWITZERLAND Press Release New-Gen Resorbable Magnesium Scaffold Freesolve Enters BIOMAG-II Randomized Controlled Trial (RCT) BIOTRONIK announced today the enrollment of the first patient in the BIOMAG-II trial aiming to evaluate the safety and clinical performance of its new-generation resorbable magnesium scaffold (RMS), Freesolve™, compared to a contemporary drug-eluting stent (DES). "We are delighted to enroll the first patient in the BIOMAG-II trial, which may play a critical role in helping establish resorbable metallic scaffolds as part of clinical practice in the future and I am particularly encouraged by the implantation results of the Freesolve resorbable magnesium scaffold," said Dr. Juan F. Iglesias, HUG
Image May 13, 2024 BUELACH, SWITZERLAND Press Release New-Gen Resorbable Magnesium Scaffold Freesolve Enters BIOMAG-II Randomized Controlled Trial (RCT) BIOTRONIK announced today the enrollment of the first patient in the BIOMAG-II trial aiming to evaluate the safety and clinical performance of its new-generation resorbable magnesium scaffold (RMS), Freesolve™, compared to a contemporary drug-eluting stent (DES). "We are delighted to enroll the first patient in the BIOMAG-II trial, which may play a critical role in helping establish resorbable metallic scaffolds as part of clinical practice in the future and I am particularly encouraged by the implantation results of the Freesolve resorbable magnesium scaffold," said Dr. Juan F. Iglesias, HUG
Image April 22, 2024 BERLIN, Germany Press Release BIOTRONIK and Texray Establish Collaboration to Distribute Texray’s Innovative Radiation Protection Products BIOTRONIK , a leading global medical technology company specializing in innovative cardiovascular and endovascular solutions, proudly announces a multinational distribution partnership with Texray, the pioneering developer of a groundbreaking radiation protection textile. In this collaboration BIOTRONIK will distribute Texray's head and neck protectors starting in selected European and Middle Eastern countries. Both partners aim to raise awareness about the critical importance of radiation protection for healthcare professionals, who serve in environments where radiation exposure is an
Image April 22, 2024 BERLIN, Germany Press Release BIOTRONIK and Texray Establish Collaboration to Distribute Texray’s Innovative Radiation Protection Products BIOTRONIK , a leading global medical technology company specializing in innovative cardiovascular and endovascular solutions, proudly announces a multinational distribution partnership with Texray, the pioneering developer of a groundbreaking radiation protection textile. In this collaboration BIOTRONIK will distribute Texray's head and neck protectors starting in selected European and Middle Eastern countries. Both partners aim to raise awareness about the critical importance of radiation protection for healthcare professionals, who serve in environments where radiation exposure is an